Answers are grounded in this paper and cite their sources.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic, debilitating condition characterized by persistent pelvic pain and lower urinary tract symptoms (LUTS). The prevalence of IC/BPS in Japan may be greater than previously estimated. The goal of this cross-sectional study was to estimate IC/BPS prevalence and its effect on health-related quality of life (HRQoL). A total of 6,210 participants participated in the Japan Community-based Cohort Study 2023 (JaCS2023). The questionnaire comprised 146 items covering demographics, LUTS, QoL, and healthcare utilization. Participants were categorized based on LUTS and bladder pain: IC/BPS and Non-IC/BPS controls. Prevalence of IC/BPS was 0.601%, with higher prevalence in females. IC/BPS patients exhibited significantly lower HRQoL, with mental health and sleep/energy being the most severely affected. The majority of symptomatic individuals remained undiagnosed and untreated. Additionally, patients with IC/BPS demonstrated localized bladder pain and a broad spectrum of storage and voiding dysfunction. These findings indicate that the prevalence of IC/BPS in Japan may be substantially greater than previously estimated. Addressing this treatment gap, wherein the majority of patients remain undiagnosed, is essential to mitigate its profound effect on HRQoL. Early identification and intervention guided by precise epidemiological estimations are critical for managing this disease.
No takes yet. Share an insight, caveat, or question.
Miyazato et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: